IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 41 - 2025

2025-10-15 12:01:23

(MENAFN- GlobeNewsWire - Nasdaq)

Aggregated presentation by day and by market Statement of transactions in own shares from October 06th to October 10th 2025

Name of the issue	Identity code of the issuer (Legal Entity Identifier)	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares	Market (MIC Code)
IPSEN	549300M6SGDPB4Z94P11	06/10/2025	FR0010259150	300	115,30	AQEU
IPSEN	549300M6SGDPB4Z94P11	06/10/2025	FR0010259150	1300	115,21923	CCXE
IPSEN	549300M6SGDPB4Z94P11	06/10/2025	FR0010259150	200	115,10	TQEX
IPSEN	549300M6SGDPB4Z94P11	06/10/2025	FR0010259150	2201	115,92894	XPAR
IPSEN	549300M6SGDPB4Z94P11	07/10/2025	FR0010259150	100	116,20	AQEU
IPSEN	549300M6SGDPB4Z94P11	07/10/2025	FR0010259150	500	116,12	CCXE
IPSEN	549300M6SGDPB4Z94P11	07/10/2025	FR0010259150	2551	116,41846	XPAR
IPSEN	549300M6SGDPB4Z94P11	08/10/2025	FR0010259150	4300	117,61405	XPAR
IPSEN	549300M6SGDPB4Z94P11	09/10/2025	FR0010259150	460	117,70	AQEU
IPSEN	549300M6SGDPB4Z94P11	09/10/2025	FR0010259150	1000	117,80	CCXE
IPSEN	549300M6SGDPB4Z94P11	09/10/2025	FR0010259150	300	117,70	TQEX
IPSEN	549300M6SGDPB4Z94P11	09/10/2025	FR0010259150	2440	118,04947	XPAR
IPSEN	549300M6SGDPB4Z94P11	10/10/2025	FR0010259150	400	116,70	AQEU
IPSEN	549300M6SGDPB4Z94P11	10/10/2025	FR0010259150	2000	117,15	CCXE
IPSEN	549300M6SGDPB4Z94P11	10/10/2025	FR0010259150	240	116,80	TQEX
IPSEN	549300M6SGDPB4Z94P11	10/10/2025	FR0010259150	2400	117,59371	XPAR
				20692	117,02533

Attachment

EN_IPSEN - Buy-back programme - Art 5 of MAR - Week 41_2025

MENAFN15102025004107003653ID1110201277

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.